Jump to content

Publication: Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme

From CAMIH
Revision as of 11:18, 30 September 2024 by EProba (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Reference
Title Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme
Topic Enzymes (bromelain papain)
Author Stauder, G, Beaufort, F, Streichhan, P
Year 1991
Journal Deutsche Zeitschrift für Onkologie
DOI

Author's Abstract The abstract and the information and conclusions contained therein were written by the authors of the publication.

In this randomized prospective clinical trial hydrolytic enzymes were given addionally to radiation in abdominal cancer patients and compared with radiation only. The concomitant oral enzyme therapy improved the tolerance of the radiation significantly. The enzyme treated patients had less deterioration of general condition and skin symptomes and less patients discontinued radiation. It reduced the number of drugs needed for the treatment od radiation avderse effects, especially antiemetics, gastrointestinal drugs, antidepressives, tranquilizers and other psychopharmaceuticals, analgetics, spamolytics, diuretics and aldosteron antagonists. In most cases the enzyme therapy was well or very well tolerated.



This publication is referenced in the following studies:

  1. Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme